Clinical Trials Directory

Trials / Completed

CompletedNCT02379559

Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men

An Exercise Intervention on Metabolic Syndrome and Prostate Cancer Risk Among Black Men

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Georgetown University · Academic / Other
Sex
Male
Age
40 Years – 40 Years
Healthy volunteers
Accepted

Summary

The main purpose of this study is to examine the feasibility of an exercise intervention on metabolic syndrome (MetS) components and biomarkers related to prostate cancer in Black men with MetS who are at increased risk of prostate cancer.

Detailed description

The specific aim for the proposed study is to examine the feasibility and impact of a 6-month two-arm randomized controlled trial (RCT) on MetS components and biomarkers related to prostate cancer in Black men with MetS. Due to the striking racial disparities of prostate cancer, this proposal will focus on the impact of an aerobic and resistance exercise intervention on MetS and biomarkers related to prostate cancer in Black men. Specifically, our proposed clinical trial compares an aerobic and resistance exercise intervention to an attention control group among Black men.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExerciseFor the first 12-weeks, participants will come to our community based research office for up to 50 min/session, 3-days/week of supervised exercise. Exercise duration will increase from 75 min/wk at week 1 to 150 min/wk by week 4. Thereafter, men will maintain 150 min/wk of moderate-intensity physical activity.
BEHAVIORALAttention ControlWe will provide weekly healthy lifestyle tips via text messages, and will include tips such as managing stressors in life and getting better sleep.

Timeline

Start date
2013-07-01
Primary completion
2017-02-16
Completion
2017-02-16
First posted
2015-03-05
Last updated
2017-02-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02379559. Inclusion in this directory is not an endorsement.